Envista Schedules Fourth Quarter 2025 Earnings Call
Rhea-AI Summary
Envista (NYSE: NVST) will report fourth quarter 2025 financial results on Thursday, February 5, 2026. A conference call to discuss results will begin at 2:00 PM PT and run about one hour.
The call and accompanying slide presentation will be webcast on the company Investors website (www.envistaco.com). A replay of the webcast will be available shortly after the presentation and will remain available for one year. Dial-in numbers: 1-800-836-8184 (U.S.) or 1-646-357-8785 (outside U.S.) and reference Conference ID #54406. Earnings release, slides, and presentation materials will be posted to the Investors site prior to the call and remain available after the call.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
NVST is down 1.21% while peers show mixed moves: ICUI (-0.46%), WRBY (+5.21%), XRAY (-0.16%), TFX (+0.86%), BLCO (+0.17%). This points to stock-specific trading rather than a unified sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 25 | Conference participation | Neutral | -0.3% | Announcement of participation in Evercore Healthcare investor conference with webcast access. |
| Oct 29 | Earnings results | Positive | -0.4% | Q3 2025 results with strong growth, raised EPS guidance, but slight negative price reaction. |
| Oct 29 | Sustainability report | Positive | -0.4% | Release of 2024 Sustainability Report detailing ESG progress and initiatives. |
| Sep 30 | Earnings call schedule | Neutral | -0.1% | Scheduling of Q3 2025 earnings conference call and webcast logistics. |
| Jul 31 | Earnings results | Positive | +10.3% | Strong Q2 2025 results with higher sales, EPS, and raised full-year guidance. |
Earnings result releases have triggered larger moves (notably Q2 2025), while scheduling/IR and sustainability items have historically produced minimal price changes.
Over the last six months, Envista’s news flow has centered on quarterly results, earnings calls, sustainability reporting, and conference participation. Q2 2025 results on Jul 31 saw a strong positive reaction, while Q3 2025 results on Oct 29 were followed by a slight decline despite improved metrics and raised guidance. Scheduling-related earnings calls, such as the Q3 2025 call on Sep 30, and broader corporate updates have generally coincided with very small price moves. Today’s scheduling of the Q4 2025 earnings call fits that lower-impact category.
Market Pulse Summary
This announcement sets the timetable and access details for Envista’s Q4 2025 earnings release and conference call on February 5, 2026 at 2:00 PM PT. Historically, similar scheduling headlines have produced minimal standalone impact compared with full earnings reports. Investors may focus on how upcoming results relate to prior quarters’ sales, margin trends, and guidance updates, while using the webcast and one-year replay to review management’s commentary in detail.
AI-generated analysis. Not financial advice.
The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 1-800-836-8184 within the
Envista's earnings press release, the webcast slides, and other related presentation materials will be posted to the "Investors" section of Envista's website before the conference call and will remain available following the call.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. Learn more at http://envistaco.com.
FOR FURTHER INFORMATION
Jim Gustafson
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Telephone: (714) 817-7000
ir@envistaco.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-schedules-fourth-quarter-2025-earnings-call-302656866.html
SOURCE Envista Holdings Corporation